NCT03334448View on ClinicalTrials.gov

A Study to Compare 2 Formulations of LY900014 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

March 15, 2018

Study Completion Date

March 15, 2018

Conditions
Healthy
Interventions
DRUG

LY900014-U200

Administered SC

DRUG

LY900014-U100

Administered SC

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03334448 - A Study to Compare 2 Formulations of LY900014 in Healthy Participants | Biotech Hunter | Biotech Hunter